Activity Stream
@moatrx
• one week ago
Posted a new blog:
GCC MYASTHENIA GRAVIS LAUNCH READINESS
GCC MYASTHENIA GRAVIS LAUNCH READINESS
Refractory gMG in the GCC is a 200 to 300 patient market run by fewer than 15 named neurologists, not a clinical proof problem.
Efgartigimod (Vyvgart) was recently...
